SLNOSOLENO THERAPEUTICS INC
CUSIP 834203309 · common stock
No tracked investor reported shares of SOLENO THERAPEUTICS INC (SLNO) for Q2 2026. 2 investors sold out this quarter, including Adar1 Capital Management.
Holders · Q2 2026
0
New holders
0
Value held
$0
Quarter-end price (est.)
—
Investors holding SLNO · Q2 2026
No tracked investor reported shares this quarter.
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Adar1 Capital Management | 0.09% | 46,830 | $1.6M | EXIT |
| Joel Greenblatt | 0.00% | 13,702 | $458.7K | EXIT |